Karuna Therapeutics Inc. (KRTX)
Karuna Therapeutics Statistics
Share Statistics
Karuna Therapeutics has 38.2M shares outstanding. The number of shares has increased by 0% in one year.
| 38.2M |
| 0% |
| 0% |
| n/a |
| n/a |
| 3 |
| n/a |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -26.97 and the forward PE ratio is null. Karuna Therapeutics's PEG ratio is -0.79.
| -26.97 |
| n/a |
| 17886.71 |
| n/a |
| 9.33 |
| -30.09 |
| -0.79 |
Enterprise Valuation
Karuna Therapeutics has an Enterprise Value (EV) of 11.53B.
| 17628.09 |
| -23.38 |
| -29.88 |
| -29.66 |
Financial Position
The company has a current ratio of 19.31, with a Debt / Equity ratio of 0.01.
| 19.31 |
| 18.82 |
| 0.01 |
| -0.03 |
| -0.04 |
| 0 |
Financial Efficiency
Return on Equity is -34.58% and Return on Invested Capital is -38.99%.
| -34.58% |
| -32.46% |
| -38.99% |
| $1,929.2 |
| $-1,279,292.04 |
| 339 |
| 0 |
| 0.05 |
Taxes
| 670K |
| -0.15% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.15, so Karuna Therapeutics's price volatility has been higher than the market average.
| 1.15 |
| n/a |
| 317.67 |
| 228.83 |
| 75.4 |
| 971,825 |
Income Statement
In the last 12 months, Karuna Therapeutics had revenue of 654K and earned -433.68M in profits. Earnings per share was -11.73.
| 654K |
| -1.05M |
| -494.78M |
| -433.68M |
| -493.08M |
| n/a |
| -11.73 |
Balance Sheet
The company has 185.82M in cash and 16.69M in debt, giving a net cash position of 169.13M.
| 185.82M |
| 16.69M |
| 169.13M |
| -997.89M |
| 1.34B |
| 1.25B |
Cash Flow
In the last 12 months, operating cash flow was -385.82M and capital expenditures -2.92M, giving a free cash flow of -388.74M.
| -385.82M |
| -2.92M |
| -388.74M |
| -10.52 |
Margins
Gross margin is -160.09%, with operating and profit margins of -75653.98% and -66311.93%.
| -160.09% |
| -75653.98% |
| -66209.48% |
| -66311.93% |
| -75393.88% |
| -75653.98% |
| -59439.76% |
Dividends & Yields
KRTX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -3.71% |
| -3.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 91.07 |
| 1 |